Literature DB >> 1723148

Processing of the Plasmodium falciparum major merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion.

M J Blackman1, H Whittle, A A Holder.   

Abstract

We have previously shown that only a single 19-kDa fragment of the Plasmodium falciparum major merozoite surface protein (MSP1) is carried with an invading merozoite into the infected red cell. This fragment (MSP1(19] is derived from the C-terminal membrane-bound end of a major product, MSP1(42), of the primary stage of MSP1 proteolytic processing. Using a monoclonal antibody mapped to an epitope within the N-terminal region of MSP1(42), we have shown that a soluble 33-kDa polypeptide (MSP1(33) corresponding to the N-terminal region of MSP1(42) is shed into culture supernatants during merozoite release and erythrocyte invasion. These observations provide further evidence that the secondary processing of MSP1(42) involves a highly site-specific proteolytic activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723148     DOI: 10.1016/0166-6851(91)90128-s

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  62 in total

1.  Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum.

Authors:  L Wang; C G Black; V M Marshall; R L Coppel
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system.

Authors:  Alan L Y Pang; Caryn N Hashimoto; Leslie Q Tam; Z Q Meng; George S N Hui; Walter K K Ho
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

3.  PFE0565w, a Plasmodium falciparum protein expressed in salivary gland sporozoites.

Authors:  Maggie S Schlarman; Renee N Roberts; Michael M Kariuki; Alexis N LaCrue; Ruguang Ou; Brenda T Beerntsen
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

4.  Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development.

Authors:  David K Moss; Edmond J Remarque; Bart W Faber; David R Cavanagh; David E Arnot; Alan W Thomas; Anthony A Holder
Journal:  Infect Immun       Date:  2011-12-27       Impact factor: 3.441

5.  A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum.

Authors:  Anthony W Stowers; Li-how Chen Lh; Yanling Zhang; Michael C Kennedy; Lanling Zou; Lynn Lambert; Timothy J Rice; David C Kaslow; Allan Saul; Carole A Long; Harry Meade; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 6.  Microneme proteins in apicomplexans.

Authors:  Vern B Carruthers; Fiona M Tomley
Journal:  Subcell Biochem       Date:  2008

7.  Global identification of multiple substrates for Plasmodium falciparum SUB1, an essential malarial processing protease.

Authors:  Natalie C Silmon de Monerri; Helen R Flynn; Marta G Campos; Fiona Hackett; Konstantinos Koussis; Chrislaine Withers-Martinez; J Mark Skehel; Michael J Blackman
Journal:  Infect Immun       Date:  2011-01-10       Impact factor: 3.441

8.  Lineage-specific positive selection at the merozoite surface protein 1 (msp1) locus of Plasmodium vivax and related simian malaria parasites.

Authors:  Hiromi Sawai; Hiroto Otani; Nobuko Arisue; Nirianne Palacpac; Leonardo de Oliveira Martins; Sisira Pathirana; Shiroma Handunnetti; Satoru Kawai; Hirohisa Kishino; Toshihiro Horii; Kazuyuki Tanabe
Journal:  BMC Evol Biol       Date:  2010-02-19       Impact factor: 3.260

9.  Antibody-dependent transplacental transfer of malaria blood-stage antigen using a human ex vivo placental perfusion model.

Authors:  Karen May; Markus Grube; Indu Malhotra; Carole A Long; Sanjay Singh; Kishor Mandaliya; Werner Siegmund; Christoph Fusch; Henning Schneider; Christopher L King
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

10.  Phase 1 trial of the Plasmodium falciparum blood stage vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in malaria naïve adults.

Authors:  Ruth D Ellis; Laura B Martin; Donna Shaffer; Carole A Long; Kazutoyo Miura; Michael P Fay; David L Narum; Daming Zhu; Gregory E D Mullen; Siddhartha Mahanty; Louis H Miller; Anna P Durbin
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.